Profiel
Takeshi Takahashi is currently the Director at Pathalys Pharma, Inc. He previously worked as an Independent Director at Mineralys Therapeutics, Inc. from 2020 to 2023.
He also held the position of Co-Chief Operating Officer & Manager-Technology II at Tsugami Corp.
Mr. Takahashi completed his undergraduate degree at Waseda University and holds an MBA from Kellogg School of Management.
Actieve functies van Takeshi Takahashi
| Bedrijven | Functie | Begin |
|---|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease | Directeur/Bestuurslid | - |
Eerdere bekende functies van Takeshi Takahashi
| Bedrijven | Functie | Einde |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Directeur/Bestuurslid | 12-09-2023 |
| TSUGAMI CORPORATION | Operationeel Directeur | - |
Opleiding van Takeshi Takahashi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Tsugami Corp.
Tsugami Corp. Industrial MachineryProducer Manufacturing Engages in the manufacture and sale of precision machine tools | Producer Manufacturing |
Waseda University
Waseda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease | Health Technology |
















